Last reviewed · How we verify

NCT06882304

PREVALENCE OF WHITE SPOT LESIONS IN ENAMEL AFTER ORTHODONTIC TREATMENT IN YOUNG ADULTS

Not yet recruiting Last updated 18 March 2025
What this trial tests

trial testing orthodontic treatment in White Spot Lesion in 368 participants. Not yet recruiting.

Timeline
1 August 2025
Primary endpoint
1 September 2026
1 October 2027

Quick facts

Lead sponsorCairo University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment368
Start date1 August 2025
Primary completion1 September 2026
Estimated completion1 October 2027

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 30, any sex, with White Spot Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to measure prevalence of enamel white spot lesions in enamel in young adults after orthodontic treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of orthodontic treatment

Trials testing the same drug.

Other recruiting trials for White Spot Lesion

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06882304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing